PURIFICATION OF INTERLEUKIN-2 ANTIBODIES FROM HEALTHY-INDIVIDUALS

被引:20
作者
MONTI, E
POZZI, A
TIBERIO, L
MORELLI, D
CARUSO, A
VILLA, ML
BALSARI, A
机构
[1] UNIV BRESCIA,DEPT BIOMED SCI & BIOTECHNOL,I-25123 BRESCIA,ITALY
[2] UNIV MILAN,SCH MED,CHAIR IMMUNOL,I-20122 MILAN,ITALY
[3] INST MICROBIOL,I-25123 BRESCIA,ITALY
关键词
INTERLEUKIN; 2; NATURAL ANTIBODY; AFFINITY CHROMATOGRAPHY;
D O I
10.1016/0165-2478(93)90098-M
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By covalent binding of recombinant interleukin-2 (rIL-2) to Sepharose, it was possible to immunopurify specific human anti-IL-2 antibodies from a pool of immunoglobulins obtained from healthy subjects. Since low quantities of the ligand released by the matrix could interfere with the evaluation of the biological activity of anti-IL-2 antibodies, the antibody preparation was subjected to pepsin digestion which is known to destroy the IL-2 molecule. Purified human anti-IL-2 antibodies were found to be mostly IgG1 and able to neutralize IL-2 induced peripheral blood lymphocytes (PBL) proliferation in vitro. The availability of purified anti-IL-2 antibodies, obtained from healthy individuals, able to modulate IL-2 activity, could be important in several therapeutic approaches.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 17 条
  • [1] THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 ANTIBODIES IN PATIENTS TREATED WITH RECOMBINANT HUMAN INTERLEUKIN-2 (IL-2)
    ALLEGRETTA, M
    ATKINS, MB
    DEMPSEY, RA
    BRADLEY, EC
    KONRAD, MW
    CHILDS, A
    WOLFE, SN
    MIER, JW
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (06) : 481 - 490
  • [2] BALKWILL FR, 1989, IMMUNOL TODAY, V10, P289
  • [3] AUTOANTIBODIES TO CYTOKINES - FRIENDS OR FOES
    BENDTZEN, K
    SVENSON, M
    JONSSON, V
    HIPPE, E
    [J]. IMMUNOLOGY TODAY, 1990, 11 (05): : 167 - 169
  • [4] BOST KL, 1988, IMMUNOLOGY, V65, P611
  • [5] CARUSO A, 1990, J IMMUNOL, V144, P685
  • [6] FOMSGAARD A, 1989, SCAN J IMMUNOL, V4, P489
  • [7] IL-2 ANTIBODY-PRODUCTION IN LUPUS MICE
    ISHIZAKA, S
    TSUJII, T
    [J]. CELLULAR IMMUNOLOGY, 1989, 118 (01) : 100 - 107
  • [8] MOGENSEN KE, 1981, LANCET, V2, P1227
  • [9] PANEM S, 1982, J IMMUNOL, V129, P1
  • [10] PRUMMER O, 1989, J INTERFERON RES, V9, P67